Internal Medicine
Online ISSN : 1349-7235
Print ISSN : 0918-2918
ISSN-L : 0918-2918
Volume 60 , Issue 16
Showing 1-34 articles out of 34 articles from the selected issue
EDITORIALS
ORIGINAL ARTICLES
  • Yuichi Kojima, Toshihisa Takeuchi, Shinya Nishida, Taro Iwatsubo, Shin ...
    2021 Volume 60 Issue 16 Pages 2529-2535
    Published: August 15, 2021
    Released: August 15, 2021
    JOURNAL OPEN ACCESS

    Objective We examined the clinical course and treatment method of a case series of radiation-induced hemorrhagic gastroduodenitis with clinical signs.

    Methods This was a single-center retrospective observational study.

    Patients We included seven patients with radiation-induced hemorrhagic gastroduodenitis treated at our hospital between April 2014 and May 2020.

    Results One male patient each had cancer of the head of the pancreas, bile duct cancer, hepatocellular carcinoma, and ureteral cancer, whereas two women had recurrent endometrial cancer and one woman had recurrent cervical cancer. The onset occurred 3-5 months after the end of radiation treatment. Endoscopic examinations showed a red edematous mucous membrane in a fragile condition stretching from the antrum of the stomach to the duodenum, with telangiectasia and ulcer. For endoscopic hemostasis, five patients underwent argon plasma coagulation (APC), which was successful in three patients. Two of these were being administered an antithrombotic at the time. One case resistant to conservative treatment required repeated transfusion for recurring hemorrhaging over a short period of time and therefore underwent surgical treatment. Thereafter, the postoperative course was favorable.

    Conclusions Actively attempting hemostasis through APC and surgery is effective for treating radiation-induced hemorrhagic gastroduodenitis. The use of an antithrombotic agent might lead to a risk of repeated hemorrhaging. Therefore, repeated hemostasis through APC is crucial.

    Download PDF (1053K)
  • Yorinari Ochiai, Daisuke Kikuchi, Kosuke Nomura, Takayuki Okamura, Jun ...
    2021 Volume 60 Issue 16 Pages 2537-2543
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    Objective Esophagogastric junction outflow obstruction (EGJOO) is a diagnosis of unclear significance that has become increasingly common with recent advances in high-resolution manometry (HRM). EGJOO can be divided into mechanical or functional obstruction. Functional EGJOO is considered an incomplete phenotype or an early stage of achalasia. However, little is known about the endoscopic findings in patients with functional EGJOO. Thus, we aimed to elucidate the endoscopic findings in patients with functional EGJOO and to identify patients at high risk for achalasia.

    Methods This was a single-center retrospective study. A total of 259 patients underwent esophagogastroduodenoscopy (EGD) along with HRM for upper gastrointestinal symptoms without any obstructive lesions or stricture between July 2013 and September 2019 in our institute. Among them, 31 patients were diagnosed with EGJOO. After excluding patients who had undergone previous endoscopic treatment, those who were diagnosed with eosinophilic esophagitis and those who had undergone EGD at other institutes, 23 patients were finally included with a diagnosis of functional EGJOO. The endoscopic findings were evaluated by three endoscopists.

    Results Five patients (21.7%) had an esophageal rosette sign (ERS). No patients had grade IV gastroesophageal flap valve, esophageal mucosal breaks, or abnormal retention of liquid or food in the esophagus. Manometric findings revealed that the median distal contractile integral value was significantly higher in patients with an ERS (n=5) than in those without it (n=18).

    Conclusion There were some patients with functional EGJOO who had an ERS, which is the characteristic endoscopic finding in achalasia.

    Download PDF (737K)
  • Madoka Unno, Shinichi Hashimoto, Kensaku Shimizu, Hideko Onoda, Masahi ...
    2021 Volume 60 Issue 16 Pages 2545-2555
    Published: August 15, 2021
    Released: August 15, 2021
    JOURNAL OPEN ACCESS

    Objective CT enterography/enteroclysis (CTE) is listed in the clinical practice guidelines as a method for diagnosing small bowel bleeding, as is capsule endoscopy (CE), but there are no real-world data yet available on CTE in Japan. This study aimed to investigate the diagnostic ability of CTE and long-term prognosis after CTE in Japan.

    Patients We conducted a retrospective cohort study of patients suspected of having small bowel bleeding who underwent both CTE and CE within 30 days between April 2008 and March 2019. The number of patients free from rebleeding for up to 24 months was thus determined.

    Results Seventy-one patients were extracted from the database. The 43 patients (60.6%) with a definite and suspicious source of bleeding in the small bowel were detected by CTE. When the 31 patients with a definite source of bleeding in the small bowel were analyzed, the sensitivity of CTE was 19/31 (61.3%) and that of CE was 24/31 (77.4%), thus indicating no significant difference (p=0.332). However, the sensitivity when CTE and CE were used in combination was 30/31 (96.8%), which was significantly higher than that of CE alone (p=0.0412). No rebleeding was observed in the CTE and CE negative group (p=0.0965).

    Conclusion The combined use of CTE and CE increased the detection rate of small bowel bleeding. Therefore, in patients with suspected tumor/polyp lesions, not only CE, but also CTE should be performed. This study provides the first real-world data on the diagnostic accuracy of CTE for small bowel bleeding in Japan.

    Download PDF (542K)
  • Masaaki Watanabe, Akitaka Shibuya, Hiroaki Yokomori, Wasaburo Koizumi
    2021 Volume 60 Issue 16 Pages 2557-2568
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 15, 2021
    JOURNAL OPEN ACCESS

    Objective This study examined whether or not the Digestive Disease Week-Japan (DDW-J) 2004 scale proposed over 15 years ago can be applied to current cases of drug-induced liver injury (DILI).

    Methods The new patients group included 125 patients from 2012 to 2019 and was divided into 2 subgroups: 96 patients in the new DILI group and 29 patients in the new non-DILI group. Similarly, the old patients group included 105 patients from 1997 to 2002 and was divided into 2 subgroups: 59 patients in the old DILI group and 46 patients in the old non-DILI group. Patients were assessed by the DDW-J 2004 scale; those with a score ≥3 were defined as having DILI.

    Results The total score of the new DILI group was significantly lower than that of the old DILI group [6 (1-11) vs. 6 (3-9), p=0.004]. The sensitivity, specificity, positive predictive value, and negative predictive value (NPV) were 94.8%, 65.6%, 90.1%, and 79.2%, respectively, in the new patients group and 100%, 91.4%, 93.7%, and 100%, respectively, in the old patients group. The specificity and NPV of the new patients group were significantly lower than those of the old patients group.

    Conclusion The DDW-J 2004 scale maintains a stable diagnostic ability for DILI, regardless of differences in eras and verification methods. However, differential diagnoses can affect the scoring, and new types of DILI, such as immune-related adverse events, must be addressed. Therefore, upgrading the scale should be considered.

    Download PDF (408K)
  • Tomoyasu Nishimura, Yoshifumi Uwamino, Shunsuke Uno, Shoko Kashimura, ...
    2021 Volume 60 Issue 16 Pages 2569-2575
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: June 19, 2021
    JOURNAL OPEN ACCESS

    Objective To consider effective measures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in medical institutions, this study estimated the SARS-CoV-2 infection rate among healthcare workers (HCWs) in Tokyo, Japan, and determined the specific findings for mild coronavirus disease 2019 (COVID-19) cases.

    Methods This study analyzed the results of serologic tests to detect immunoglobulin G antibodies against SARS-CoV-2 and evaluated the demographic and clinical characteristics of the faculty and HCWs at a Tokyo medical institution in August 2020. The demographic and clinical characteristics of participants with antibody-positive results were compared to those of participants with antibody-negative results.

    Materials This study recruited 2,341 faculty and HCWs at a Tokyo medical institution, 21 of whom had a COVID-19 history.

    Results Of the 2,320 participants without a COVID-19 history, 20 (0.862%) had positive serologic test results. A fever and dysgeusia or dysosmia occurred with greater frequency among the participants with positive test results than in those with negative results [odds ratio (OR), 5.475; 95% confidence interval (CI), 1.960-15.293 and OR, 24.158; 95% CI, 2.693-216.720, respectively]. No significant difference was observed in the positivity rate between HCWs providing medical care for COVID-19 patients using adequate protection and other HCWs (OR, 2.514; 95% CI, 0.959-6.588).

    Conclusion To reduce the risk of COVID-19 spread in medical institutions, faculty and HCWs should follow standard and necessary transmission-based precautions, and those with a fever and dysgeusia or dysosmia should excuse themselves from work as soon as possible.

    Download PDF (220K)
  • Kunihisa Miwa
    2021 Volume 60 Issue 16 Pages 2577-2584
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: April 26, 2021
    JOURNAL OPEN ACCESS

    Objective Central nervous system dysfunction associated with myalgic encephalomyelitis (ME) has been suggested to be the main cause of chronic fatigue syndrome. In animal models of chronic fatigue, minocycline was reported to act as a suppressor of neural inflammation. Minocycline may thus exert favorable therapeutic effects in patients with ME.

    Methods Oral minocycline (100 mg×2 on the first day, followed by 100 mg/day for 41 days) was administered to 100 patients with ME. The performance status score (0-9), orthostatic intolerance during the 10-min standing test, neurologic disequilibrium, and neuropathic pain were compared before and after treatment.

    Results After therapy completion, favorable effects were observed with a decrease in the performance status score of ≥2 points in 27 patients (27%). Before treatment, 6 of the 27 patients had orthostatic intolerance with an inability to complete the 10-min standing test; after treatment, this symptom resolved in 4 and improved in 2 patients. In addition, after treatment, postural orthostatic tachycardia resolved in five of eight patients, disequilibrium resolved in five of eight patients, and fibromyalgia or neuropathic pain was attenuated in four of five patients. The favorable effects appeared dependent on a shorter disease duration, primarily for a duration of less than three years and most frequently within six months of the disease onset. However, acute adverse effects with nausea and/or dizziness caused 38 patients (38%) to discontinue treatment in the first few days.

    Conclusion Oral minocycline therapy may be an effective treatment option for patients with ME, especially in the initial stage of the disease.

    Download PDF (168K)
  • Takeshi Mochizuki, Koichiro Yano, Katsunori Ikari, Ken Okazaki
    2021 Volume 60 Issue 16 Pages 2585-2591
    Published: August 15, 2021
    Released: August 15, 2021
    JOURNAL OPEN ACCESS

    Objectives We aimed to investigate the safety of zoledronic acid (ZOL) combined with acetaminophen (APAP) regarding both the adverse events and the efficacy of ZOL combined with an eldecalcitol (ELD) in a randomized clinical trial conducted in patients with primary osteoporosis.

    Methods A total of 109 patients were administered ZOL 5 mg and then were randomly assigned to the following groups (3:2:1): those treated with ZOL, those treated with ZOL combined with APAP and ELD, and those treated with ZOL combined with ELD. For the analyses, the groups were classified into four treatment groups: patients treated with APAP (APAP group) and without APAP (non-APAP group), and those treated with ELD (ELD group) and without ELD (non-ELD group). The incidence rates of symptomatic adverse events were compared between the APAP and non-APAP groups, and the efficacy was compared between the ELD and non-ELD groups.

    Results In the APAP and non-APAP groups, the incidence rates of symptomatic adverse events were 20.6% and 44.6% (p=0.009), respectively. Age and APAP use were found to be significant factors associated with adverse events. The percent changes in the bone mineral density values from baseline (ΔBMD) in the ELD and non-ELD groups at 12 months were 8.2% and 6.2% for the lumbar spine, 4.2% and 4.0% for the total hip, and 3.9% and 2.2% for the femoral neck, respectively. The ΔBMD of all sites did not differ significantly between the ELD and non-ELD groups.

    Conclusion In ZOL treatment, the co-administration of APAP should thus be considered as a therapeutic option to reduce the occurrence of symptomatic adverse events stemming from ZOL treatment in Japanese patients with primary osteoporosis, particularly in younger patients.

    Download PDF (503K)
CASE REPORTS
  • Takao Sato, Ryota Sagami, Hidefumi Nishikiori, Hiroaki Tsuji, Keiji Sa ...
    2021 Volume 60 Issue 16 Pages 2593-2599
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 15, 2021
    JOURNAL OPEN ACCESS

    We herein report an extremely rare case of adenocarcinoma of the minor duodenal papilla (MiDP) which was successfully treated by endoscopic mucosal resection (EMR). An asymptomatic 84-year-old man underwent upper gastrointestinal endoscopy, which revealed a slightly elevated lesion at the MiDP. The biopsy findings were suggestive of adenocarcinoma. Computed tomography, magnetic resonance images and endoscopic ultrasonography did not reveal pancreatic tumor infiltration nor any apparent distant metastases. Therefore, we treated the lesion using EMR with complete resection. No recurrence or metastasis has been detected at 13 months after EMR. Total resection of the MiDP can thus serve as a relatively safe and simple treatment.

    Download PDF (1381K)
  • Tadanobu Aragaki, Nobuyoshi Tomomatsu, Yasuyuki Michi, Hisashi Hosaka, ...
    2021 Volume 60 Issue 16 Pages 2601-2605
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    Pyogenic granuloma (PG) is a granulomatous elevated lesion that occurs on the skin and mucous membranes. We herein report two cases of intra-oral PG that developed during the administration of ramucirumab for gastric cancer. Case 1 involved a 55-year-old man with a 6-mm tumor on the right tongue, and case 2 involved a 67-year-old man with a 5-mm tumor on the upper lip. The imbalance in angiogenesis caused by ramucirumab and the deterioration in the local oral environment were suggested to have caused the PG. Medical and dental collaboration is essential during the administration of ramucirumab.

    Download PDF (922K)
  • Haruo Miwa, Kazuya Sugimori, Tomohiro Ishii, Akihiro Funaoka, Hiromi T ...
    2021 Volume 60 Issue 16 Pages 2607-2612
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 01, 2021
    JOURNAL OPEN ACCESS

    A 74-year-old woman with a cyst in her pancreatic tail was referred to our hospital. Computed tomography confirmed a large cystic lesion with irregular wall thickening, abdominal lymph node swelling, and ascites. We diagnosed her with an unresectable mucinous cystic neoplasm, since ascites cytology revealed adenocarcinoma. The patient received chemotherapy up to the fifth line for 55.2 months. Gemcitabine plus nab-paclitaxel and modified FOLFIRINOX achieved a partial response with a progression-free survival time of 12.1 and 20.4 months, respectively. The overall survival time from the beginning of first-line chemotherapy was 69.4 months.

    Download PDF (949K)
  • Yuichi Takano, Jun Noda, Masataka Yamawaki, Tetsushi Azami, Takahiro K ...
    2021 Volume 60 Issue 16 Pages 2613-2615
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    Endoscopic transpapillary gallbladder drainage (ETGBD) is an established procedure and is listed in the Tokyo guidelines 2018. Although there are many reports of ETGBD in normal anatomy cases, it is rarely performed for patients with a surgically altered anatomy. We herein report the case of a patient who underwent ETGBD with Billroth-II reconstruction. ETGBD could be an effective treatment option even for patients with a surgically altered anatomy.

    Download PDF (777K)
  • Seiya Kato, Ryotaro Sakamori, Ryoko Yamada, Kazuhiro Murai, Teppei Yos ...
    2021 Volume 60 Issue 16 Pages 2617-2622
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    We herein report the first case of interventional radiology for a left gastric vein aneurysm with a gastrorenal shunt. The etiology of the aneurysm was considered secondary to portal hypertension and liver cirrhosis due to hepatitis B virus infection. As the aneurysm was asymptomatic but had a tendency to expand, we successfully performed coil embolization for the aneurysm through a gastrorenal shunt.

    Download PDF (7919K)
  • Masami Abe, Suguru Chiba, Sayuri Kataoka, Yoshikatsu Gima, Chikashi Na ...
    2021 Volume 60 Issue 16 Pages 2623-2626
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: June 19, 2021
    JOURNAL OPEN ACCESS

    Cardiac involvement has been reported in patients with coronavirus disease 2019 (COVID-19). We herein report a 41-year-old man who presented with recurrent paroxysmal atrioventricular block without showing significant cardiac injuries or comorbidities. The patient was diagnosed with COVID-19 and admitted to our hospital, where he was noted to have paroxysmal atrioventricular block. Cardiac biomarkers, echocardiography, and cardiac magnetic resonance imaging findings were fairly normal. An endomyocardial biopsy performed before the implantation of a permanent pacemaker revealed mild myocardial fibrosis without inflammatory infiltrates. The unusual myocardial involvement of the novel coronavirus was suspected.

    Download PDF (1169K)
  • Satoshi Nakawatase, Yoshinori Asae, Yoshiyuki Miyamoto, Masaoki Miyamo ...
    2021 Volume 60 Issue 16 Pages 2627-2631
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    We herein report the case of a 79-year-old man who presented with right-sided heart failure (HF) 27 years after undergoing surgery for tetralogy of Fallot. The HF did not respond well to oral diuretics. Transthoracic echocardiography and chest X-ray failed to determine the cause of the HF for three years. An intrapericardial mass located just behind the sternum, was finally identified on computed tomography. The mass had compressed the right ventricle, causing right-sided HF. Pre-surgical diagnostic images led to suspicion of a chronic expanding intrapericardial hematoma (CEIH), and the CEIH was surgically removed. The patient's symptoms improved markedly.

    Download PDF (1909K)
  • Yui Nakayama, Toshiyuki Furukawa, Marika Yamada, Makoto Takano, Ikutar ...
    2021 Volume 60 Issue 16 Pages 2633-2637
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 01, 2021
    JOURNAL OPEN ACCESS

    We herein report the case of a 20-year-old man with a history of epilepsy who presented with frequent transient loss of consciousness (T-LOC) and polymorphic ventricular tachycardia (VT) with QT interval prolongation. Blood investigations revealed panhypopituitarism. Following a biopsy, he was diagnosed with brain germinoma. During the biopsy, he had an episode of polymorphous VT with QT prolongation. There was no recurrence of T-LOC following chemotherapy and hormone replacement therapy. This case indicates the importance of checking the QT interval in patients with T-LOC, including those with seizures and brain tumors, to ensure appropriate treatment.

    Download PDF (1636K)
  • Shinnosuke Kikuchi, Kiyoshi Hibi, Kouichi Tamura, Kazuo Kimura
    2021 Volume 60 Issue 16 Pages 2639-2643
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 15, 2021
    JOURNAL OPEN ACCESS

    We encountered a case of ST-segment elevation myocardial infarction (STEMI) as the first clinical manifestation of essential thrombocythemia (ET). Platelet function tests revealed high thrombogenicity during primary percutaneous coronary intervention compared with general cardiovascular patients, whereas the platelet function two weeks after admission was effectively suppressed by dual antiplatelet therapy. The patient, who lacked cytoreduction, suffered from recurrent STEMI because of poor compliance with antiplatelet drugs. The risk of acute coronary occlusion may be high during the acute phase of STEMI in ET patients because of high thrombogenicity. Insufficient antiplatelet therapy and no cytoreduction are also risk factors for recurrent coronary events.

    Download PDF (1121K)
  • Miyuki Kodama, Daisuke Hirai, Seijiro Tsuji, Jaegi Shim, Mitsuteru Koi ...
    2021 Volume 60 Issue 16 Pages 2645-2649
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 01, 2021
    JOURNAL OPEN ACCESS

    A 60-year-old man presented to the emergency department with lightheadedness. He had severe hyponatremia (109 mEq/L) complicated by acute kidney injury (AKI) (serum creatinine: 9.08 mg/dL). Because he was somnolescent, his hyponatremia was initially treated by administering a 130-mL bolus of 3% saline 2 to 5 times per day for 5 days. He subsequently underwent intermittent hemodialysis without any neurological problems. Previous reports have described patients with hyponatremia and AKI being treated with continuous renal replacement therapy. However, our strategy might be a feasible, low-cost treatment strategy of treating patients with hyponatremia and AKI who do not require immediate hemodialysis.

    Download PDF (140K)
  • Yamei Cheng, Luying Guo, Meifang Wang, Jianghua Chen, Rending Wang
    2021 Volume 60 Issue 16 Pages 2651-2657
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    We herein report the case of a kidney transplant patient with recurrence of obstructive nephropathy that was not diagnosed as adenine phosphoribosyltransferase (APRT) deficiency until gene testing identified a pathogenic homozygous variant three years after renal transplantation. Subsequently, the patient was treated with allopurinol, and the allograft function increased progressively to normal. In addition, 20 cases of APRT deficiency in renal transplant recipients were also reviewed. We hope this case increases awareness of APRT deficiency in repeated obstructive nephropathy post-transplantation, which is a treatable disease for which the misdiagnosis or delayed diagnosis should be avoided.

    Download PDF (1398K)
  • Satoko Oka, Kazuo Ono, Masaharu Nohgawa
    2021 Volume 60 Issue 16 Pages 2659-2662
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    Histiocytic sarcoma (HS) is an extremely rare non-Langerhans cell disorder with an aggressive course and limited treatment options. HS most often presents at an advanced clinical stage, with a limited response to chemotherapy and high mortality. No standard treatment has been established for HS. We herein describe the first case of HS concomitant with laryngeal carcinoma that was promptly diagnosed and successfully treated; the condition of the patient has remained stable for 4 years with no recurrence.

    Download PDF (1220K)
  • Yoshihiro Yokota, Osamu Inatomi, Minami Nakagawa, Kazuki Kakuda, Kousu ...
    2021 Volume 60 Issue 16 Pages 2663-2666
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: June 12, 2021
    JOURNAL OPEN ACCESS

    Acquired coagulation factor V (FV) inhibitors are rare disorders in which antibodies against FV develop under various conditions. We herein report the case of a 71-year-old woman with FV inhibitor during radiochemotherapy for pancreatic cancer. Multiple purpuras suddenly appeared on her bilateral upper limbs with prolonged coagulation data (APTT 97.3 seconds). The FV activity was less than 3% and the FV inhibitor was positive (1.7 B.U./mL). Oral prednisolone induced a rapid normalization of the coagulation data and FV activity and a rapid disappearance of FV inhibitor within 7 days. Early diagnosis and treatment may therefore be important in cases of FV inhibitor.

    Download PDF (135K)
  • Eri Ohashi, Itaru Hayakawa, Yuichi Abe, Yoshiyuki Tsutsumi, Masaya Kub ...
    2021 Volume 60 Issue 16 Pages 2667-2670
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 01, 2021
    JOURNAL OPEN ACCESS

    Probst bundles are selectively seen in patients with agenesis of the corpus callosum (CC) and are thought to be homologous to the CC. We herein report a 19-year-old woman with partial agenesis of the CC. She developed acute encephalopathy during Bordetella pertussis infection. Brain magnetic resonance imaging (MRI) showed restricted diffusion of bilateral Probst bundles. She was treated with anti-epileptics and azithromycin and recovered with no neurological sequelae. Follow-up MRI showed the resolution of the diffusion abnormality. The characteristics of diffusion-weighted images on brain MRI and clinical course mimicked those in cases of clinically mild encephalopathy/encephalitis with reversible splenial lesion.

    Download PDF (1328K)
  • Atsuhiko Sugiyama, Yosuke Onishi, Kimiko Ito, Kazumoto Shibuya, Keigo ...
    2021 Volume 60 Issue 16 Pages 2671-2675
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 01, 2021
    JOURNAL OPEN ACCESS

    We herein report a case of seronegative immune-mediated necrotizing myopathy (IMNM) concurrent with anti-Kv1.4 and anti-titin antibodies. A 72-year-old Japanese woman presented with a 29-year history of fluctuating high serum creatine kinase (CK) levels followed by intermittent ptosis and respiratory muscle weakness. This case highlights the fact that marked respiratory muscle weakness requiring intubation can be seen in an ambulant patient with IMNM. Marked respiratory muscle weakness, rhabdomyolysis-like acute elevation of CK levels, and anti-striational muscle antibodies may be a characteristic constellation of findings in a distinct subgroup of patients with inflammatory myopathy with myasthenia gravis or similar symptoms.

    Download PDF (505K)
  • Juri Tatsuoka, Takahiro Igarashi, Ryuta Kajimoto, Masato Kobayashi, No ...
    2021 Volume 60 Issue 16 Pages 2677-2681
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    A 28-year-old woman experienced severe headache and right homonymous hemianopia after receiving high-dose infliximab for Crohn's disease. Computed tomography showed hemorrhagic infarction in the left temporal and parietal lobes. An angiogram revealed left transverse to sigmoid sinus occlusion and a stagnated Labbe vein. The patient was treated surgically and achieved a good outcome. Inflammatory bowel diseases are known to accompany venous and arterial thrombosis in 1-2% of cases. Recently, infliximab has been suggested to increase this possibility. A case of Crohn's disease presenting with cerebral sinus thrombosis in the remission period during long-term/high-dose use of infliximab is presented. In addition, infliximab-associated thrombosis cases were reviewed.

    Download PDF (1244K)
  • Yukiko Maeda, Kunio Toda, Sono Toi, Tetsundo Yano, Mutsumi Iijima, Yuk ...
    2021 Volume 60 Issue 16 Pages 2683-2686
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    We herein report a 73-year-old man who experienced cerebral infarction caused by infection with a Mucromycocetes species. A delay in anti-fungal treatment might result in a lethal clinical outcome. We were unable to establish an accurate diagnosis based on histological findings and cerebrospinal fluid culture. Therefore, we performed polymerase chain reaction (PCR) using paraffin-embedded specimens, and based on the findings, successfully started administering anti-fungal treatment. We suggest that PCR using sinus specimens be applied when mucormycosis is suspected as an etiology of cerebral infarction and a confirmative diagnosis cannot be established based on the results of pathological examinations or cerebrospinal fluid culture.

    Download PDF (523K)
  • Marie Tsunogae, Satoru Fujiwara, Yuma Shiomi, Yuichiro Kikawa, Nobuo K ...
    2021 Volume 60 Issue 16 Pages 2687-2691
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    We herein report a 48-year-old woman receiving eribulin mesylate for breast cancer who presented with gait disorder, distal limb paresthesia, and weakness progressing monthly. A nerve conduction study indicated demyelination with multifocal conduction block. Considering the immune-mediated pathology of her condition, she was administered intravenous immunoglobulin. Her neurological symptoms improved promptly after intravenous immunoglobulin therapy and eribulin withdrawal. Furthermore, the limb myokymia seen at the time of admission disappeared. Her symptoms continued to improve without additional treatment. We conclude that eribulin was a rare cause of demyelinating neuropathy with multifocal conduction block derived from immune-mediated pathology.

    Download PDF (1418K)
  • Tsubasa Takizawa, Isao Kurihara, Norihiro Suzuki, Jin Nakahara, Mamoru ...
    2021 Volume 60 Issue 16 Pages 2693-2696
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    Although headache attributed to hypothyroidism is coded within The International Classification of Headache Disorders, 3rd edition, an association between headache and thyrotoxicosis (hyperthyroidism) is mentioned only in the appendix. Reports on relevant cases are too scarce to establish a causal relationship. A young man with a history of migraine with aura arrived at our headache clinic with a 10-day history of headache and weight loss. Brain MRI revealed normal findings. Blood tests revealed thyrotoxicosis. A test for thyroid-related antibodies was negative. Thus, the patient was diagnosed with painless thyroiditis. The patient's headache resolved as his thyroid hormone levels decreased. To the best of our knowledge, this is the first reported case of headache exaggerated by painless thyrotoxicosis.

    Download PDF (175K)
  • Dai Kishida, Satoru Ushiyama, Yasuhiro Shimojima, Ken-ichi Ueno, Jun-i ...
    2021 Volume 60 Issue 16 Pages 2697-2700
    Published: August 15, 2021
    Released: August 15, 2021
    [Advance publication] Released: March 08, 2021
    JOURNAL OPEN ACCESS

    Panniculitis, a rare cutaneous manifestation in patients with dermatomyositis (DM), usually presents as a painful erythematous lesion. We herein report a 32-year-old woman with panniculitis that appeared as an indurated plaque without pain or redness after a 4-month episode of clinically amyopathic DM during treatment with prednisolone and tacrolimus. She experienced no pain; however, the firmness and extent gradually worsened. Based on our findings, including the histopathological results, DM panniculitis was diagnosed. Azathioprine was additionally administered, leading to remission. DM panniculitis can develop as a painless induration during immunosuppressive treatment, and azathioprine may be a useful treatment.

    Download PDF (989K)
PICTURES IN CLINICAL MEDICINE
feedback
Top